Bioatla Inc (BCAB)

OTC Markets

Currency in USD

BCAB Pro Research

1.790

-0.110(-5.79%)

Closed·18/09

Fair Value

Unlock Value

Day's Range

1.650

1.790

52 wk Range

1.070

71.500

Bioatla (BCAB) Income Statement & Profits

Assess the Bioatla income statement (earnings report) to see how the company performs across operating and non-operating activities, including revenue, expenses and net income. Review BCAB diluted EPS and profitability over the last four annual or quarterly periods.

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

0.25

Total Revenues Growth

aa.aa

-41.72%

-81.82%

Cost Of Revenues

aa.aa

58.27

79.35

103.73

63.1

43.07

Gross Profit

aa.aa

-58.02

-79.35

-103.73

-52.1

-41.07

Gross Profit Growth

aa.aa

-197.5%

-36.75%

-30.73%

+49.78%

+21.16%

Gross Profit Margin %

aa.aa

-23,209.6%

-473.59%

-2,053.65%

Other Operating Expenses, Total

aa.aa

38.42

28.79

25.96

21.85

17.63

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	+262.59%	-25.05%	-9.85%	-15.83%	-19.3%
aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	38.42	28.79	25.96	21.85	17.63
aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-96.44

-108.14

-129.69

-73.94

-58.71

Operating Income Growth

aa.aa

-220.41%

-12.13%

-19.93%

+42.98%

+20.61%

EBIT Margin %

aa.aa

-38,576%

-672.21%

-2,935.25%

Net Interest Expenses

aa.aa

0.35

1.65

6.31

3.37

0.84

Net Interest Expenses Growth

aa.aa

+126.92%

+374.93%

+283.01%

-46.63%

-74.98%

Interest Expense, Total

aa.aa

-0

Interest And Investment Income

aa.aa

0.35

1.65

6.31

3.37

0.84

Other Non Operating Expenses, Total

aa.aa

0.01

-0.09

0.8

-1.15

EBT, Excl. Unusual Items

aa.aa

-96.09

-106.48

-123.46

-69.78

-59.01

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

0.69

EBT, Incl. Unusual Items

aa.aa

-95.4

-106.48

-123.46

-69.78

-59.61

EBT, Incl. Unusual Items Growth

aa.aa

-166.09%

-11.61%

-15.95%

+43.48%

+14.57%

EBT, Incl. Unusual Items Margin

aa.aa

-38,160.8%

-634.33%

-2,980.35%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-95.4

-106.48

-123.46

-69.78

-59.61

Minority Interest

aa.aa

Net Income

aa.aa

-95.4

-106.48

-123.46

-69.78

-59.61

Net Income Growth

aa.aa

-166.09%

-11.61%

-15.95%

+43.48%

+14.57%

Net Income Margin %

aa.aa

-38,160.8%

-634.33%

-2,980.35%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-95.4

-106.48

-123.46

-69.78

-59.61

Basic EPS - Continuing Operations

aa.aa

-138.02

-136.77

-129.21

-71.83

-50.66

Basic EPS - Continuing Operations Growth

aa.aa

+13.44%

+0.9%

+5.53%

+44.41%

+29.46%

Diluted EPS - Continuing Operations

aa.aa

-138.02

-136.77

-129.21

-71.83

-50.66

Diluted EPS - Continuing Operations Growth

aa.aa

+13.44%

+0.9%

+5.53%

+44.41%

+29.46%

Basic Weighted Average Shares Outstanding

aa.aa

0.69

0.78

0.96

0.97

1.18

Diluted Weighted Average Shares Outstanding

aa.aa

0.69

0.78

0.96

0.97

1.18

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-95.11

-106.94

-128.47

-73.02

-58.33

EBITDA Growth

aa.aa

-226.94%

-12.44%

-20.13%

+43.16%

+20.11%

EBITDA Margin %

aa.aa

-38,044%

-663.8%

-2,916.6%

EBIT

aa.aa

-96.44

-108.14

-129.69

-73.94

-58.71

* In Millions of USD (except for per share items)

FAQ

What was Bioatla’s revenue at year end?

At the end of the last reported fiscal year, Bioatla (BCAB) recorded total revenue of 2.000 million USD.

How much revenue did Bioatla report in the most recent quarter?

In its most recent quarterly earnings report, Bioatla posted revenue of 6.500 million USD.

What was Bioatla’s net income for the year?

For the last full fiscal year, Bioatla reported net income of -59.607 million USD.

How much net income did Bioatla post in the last quarter?

In the most recent quarter, Bioatla (BCAB) posted net income of 0.452 million USD.

What was Bioatla’s gross profit for the year?

Gross profit for the latest fiscal year was reported at -41.073 million USD.

How much gross profit did Bioatla generate last quarter?

Bioatla recorded gross profit of 3.158 million USD in its latest quarterly report.

What was Bioatla’s annual operating income?

For the latest full fiscal year, Bioatla (BCAB) reported operating income of -58.705 million USD.

What was Bioatla’s operating income last quarter?

Quarterly operating income was 0.227 million USD.

What was Bioatla’s quarterly EBITDA?

In the latest quarter, BCAB's EBITDA was reported at 0.227 million USD.

What was the quarter-over-quarter change in EBITDA for Bioatla?

BCAB's EBITDA changed by 102.613% compared to the last quarter.

What is Bioatla’s most recent gross profit margin?

The latest reported gross profit margin for Bioatla (BCAB) is 48.585% million USD.

What is Bioatla’s most recent net income margin?

Net income margin based on recent financials is 6.954% million USD.

What is Bioatla’s most recent EBIT margin?

Bioatla reported an EBIT margin of 3.492% million USD based on current figures.

What was the quarter-over-quarter change in gross profit for Bioatla?

In the latest quarter, Bioatla's gross profit changed by 175.514%.

FTSE 100

10,659.13

-157.01

-1.45%

DAX

25,304.06

-412.65

-1.60%

Euro Stoxx 50

6,236.20

-86.70

-1.37%

S&P 500

7,650.50

+12.74

+0.17%

Nikkei 225

65,018.95

+882.70

+1.38%

Dow Jones

51,682.64

-95.40

-0.18%

FTSE 100 Futures

10,710.60

-178.4

-1.64%

Market Movers

Name	Last	Chg. %	Vol.
Sunbelt Rentals Holdings	5,422.00	-1.70%	17.54M
Shell	3,539.0	-0.90%	23.56M
AstraZeneca	12,500.0	+0.58%	6.52M
HSBC	1,512.60	-1.61%	51.22M
Glencore	556.80	-4.03%	98.16M
British American Tobacco	4,196.0	+0.29%	12.73M
Rolls-Royce Holdings	1,450.00	-2.01%	36.28M

Name	Last	Chg. %	Vol.
Nativo Resources	0.3700	+85.00%	982.07M
Dianomi	64.50	+69.74%	158.27K
Orosur	24.75	+33.78%	22.51M
Gana Media	0.0950	+26.67%	194.75M
Nostrum Oil & Gas	0.75	+25.00%	0.00
Smarter Web	52.98	+20.22%	2.33M
Team	15.00	+20.00%	1.15M

Name	Last	Chg. %	Vol.
Mothercare	0.20	-74.36%	81.38M
Future Fintech	5.59	-16.82%	3.32K
Interoil	3.13	-15.63%	762.00
ImmuPharma	3.38	-15.08%	2.34M
CanAlaska Uranium	0.30	-14.18%	26.50K
iQIYI	1.01	-12.93%	11.19K
Asiamet Resources	0.340	-12.82%	38.57M

Trending Stocks

Name	Last	Chg. %	Vol.
Nativo Resources	0.3700	+85.00%	982.07M
Airtel Africa	316.40	-11.27%	13.86M
Rolls-Royce Holdings	1,450.00	-2.01%	36.28M
IAG	419.30	-0.78%	18.80M
Barclays	462.20	-3.48%	113.79M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaa A	2,492.00	+35.63%	3,379.90
Aaaaaa Aa	558.70	+34.04%	748.88
Aaaa Aa Aa	1,606.0	+32.56%	2,128.9
Aaaaaaaaaaaaaaaaaa	301.80	+32.48%	399.82
Aaaa Aaaaaaaaaaaaa	712.40	+26.48%	901.04
Aaaaaaaaaaa Aaaa	996.0	+24.05%	1,235.5
Aaaaaa Aaa	1,877.50	+23.85%	2,325.28

Name	Last	Upside	Fair Value
Aaa Aaaaa A	2,492.00	+35.63%	3,379.90
Aaaaaa Aa	558.70	+34.04%	748.88
Aaaa Aa Aa	1,606.0	+32.56%	2,128.9
Aaaaaaaaaaaaaaaaaa	301.80	+32.48%	399.82
Aaaa Aaaaaaaaaaaaa	712.40	+26.48%	901.04
Aaaaaaaaaaa Aaaa	996.0	+24.05%	1,235.5
Aaaaaa Aaa	1,877.50	+23.85%	2,325.28

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Bioatla Inc (BCAB)

Bioatla (BCAB) Income Statement & Profits

FAQ

What was Bioatla’s revenue at year end?

How much revenue did Bioatla report in the most recent quarter?

What was Bioatla’s net income for the year?

How much net income did Bioatla post in the last quarter?

What was Bioatla’s gross profit for the year?

How much gross profit did Bioatla generate last quarter?

What was Bioatla’s annual operating income?

What was Bioatla’s operating income last quarter?

What was Bioatla’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Bioatla?

What is Bioatla’s most recent gross profit margin?

What is Bioatla’s most recent net income margin?

What is Bioatla’s most recent EBIT margin?

What was the quarter-over-quarter change in gross profit for Bioatla?

Trending Stocks